Dr. Reddy's Laboratories Limited RDY
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -71.68% | -86.94% | -18.82% | 9.84% | -0.71% |
| Total Depreciation and Amortization | 2.08% | 15.84% | 4.75% | 21.92% | 21.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.50% | -35.11% | 163.15% | -316.88% | -3.27% |
| Change in Net Operating Assets | -32.62% | 1,072.36% | 20.14% | 68.50% | 39.24% |
| Cash from Operations | -105.74% | -32.71% | 56.24% | 60.39% | 67.85% |
| Capital Expenditure | 54.79% | 43.97% | 11.66% | 33.50% | -30.88% |
| Sale of Property, Plant, and Equipment | 907.41% | 1,585.71% | -91.45% | -49.98% | -84.40% |
| Cash Acquisitions | -- | -80.18% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 152.15% | -351.31% | -309.69% | -110.71% | 21.43% |
| Cash from Investing | 118.10% | -88.40% | -78.80% | 51.99% | 7.60% |
| Total Debt Issued | -- | 275.99% | 391.02% | -84.67% | -99.34% |
| Total Debt Repaid | -1,685.58% | -62.45% | 5.88% | 45.06% | -8.67% |
| Issuance of Common Stock | 26.53% | 618.18% | 20.00% | -33.33% | 931.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | 4.10% | -- |
| Other Financing Activities | -35.08% | -46.57% | 2.09% | -118.34% | -53.63% |
| Cash from Financing | -435.67% | 190.36% | 1,149.86% | -131.62% | -112.29% |
| Foreign Exchange rate Adjustments | -80.05% | 106.52% | 6,888.51% | 913.40% | 914.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.46% | -299.33% | 374.97% | -86.42% | -148.32% |